Literature DB >> 23836215

MSCs: science and trials.

Mark F Pittenger.   

Abstract

Mesh：

Year:  2013        PMID： 23836215     DOI： 10.1038/nm.3219

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  7 in total

1.  Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.

Authors:  Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Journal:  Lancet       Date:  2004-05-01       Impact factor: 79.321

2.  Characterization of cells with osteogenic potential from human marrow.

Authors:  S E Haynesworth; J Goshima; V M Goldberg; A I Caplan
Journal:  Bone       Date:  1992       Impact factor: 4.398

3.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny.

Authors:  H Castro-Malaspina; R E Gay; G Resnick; N Kapoor; P Meyers; D Chiarieri; S McKenzie; H E Broxmeyer; M A Moore
Journal:  Blood       Date:  1980-08       Impact factor: 22.113

4.  Multilineage potential of adult human mesenchymal stem cells.

Authors:  M F Pittenger; A M Mackay; S C Beck; R K Jaiswal; R Douglas; J D Mosca; M A Moorman; D W Simonetti; S Craig; D R Marshak
Journal:  Science       Date:  1999-04-02       Impact factor: 47.728

5.  Ex vivo expansion and subsequent infusion of human bone marrow-derived stromal progenitor cells (mesenchymal progenitor cells): implications for therapeutic use.

Authors:  H M Lazarus; S E Haynesworth; S L Gerson; N S Rosenthal; A I Caplan
Journal:  Bone Marrow Transplant       Date:  1995-10       Impact factor: 5.483

6.  The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine.

Authors:  Paolo Bianco; Xu Cao; Paul S Frenette; Jeremy J Mao; Pamela G Robey; Paul J Simmons; Cun-Yu Wang
Journal:  Nat Med       Date:  2013-01-07       Impact factor: 53.440

Review 7.  Safety of cell therapy with mesenchymal stromal cells (SafeCell): a systematic review and meta-analysis of clinical trials.

Authors:  Manoj M Lalu; Lauralyn McIntyre; Christina Pugliese; Dean Fergusson; Brent W Winston; John C Marshall; John Granton; Duncan J Stewart
Journal:  PLoS One       Date:  2012-10-25       Impact factor: 3.240
  7 in total
  8 in total

Review 1.  Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.

Authors:  Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

2.  Reply to MSCs: science and trials.

Authors:  Paolo Bianco
Journal:  Nat Med       Date:  2013-07       Impact factor: 53.440

Review 3.  Mesenchymal stem cells: immune evasive, not immune privileged.

Authors:  James A Ankrum; Joon Faii Ong; Jeffrey M Karp
Journal:  Nat Biotechnol       Date:  2014-02-23       Impact factor: 54.908

4.  Precursor cells from Atlantic salmon (Salmo salar) visceral fat holds the plasticity to differentiate into the osteogenic lineage.

Authors:  Elisabeth Ytteborg; Marijana Todorcevic; Aleksei Krasnov; Harald Takle; Inger Øien Kristiansen; Bente Ruyter
Journal:  Biol Open       Date:  2015-05-06       Impact factor: 2.422

5.  Transcriptomic portrait of human Mesenchymal Stromal/Stem Cells isolated from bone marrow and placenta.

Authors:  Beatriz Roson-Burgo; Fermin Sanchez-Guijo; Consuelo Del Cañizo; Javier De Las Rivas
Journal:  BMC Genomics       Date:  2014-10-19       Impact factor: 3.969

Review 6.  Where is the common ground between bone marrow mesenchymal stem/stromal cells from different donors and species?

Authors:  Elena Jones; Richard Schäfer
Journal:  Stem Cell Res Ther       Date:  2015-08-18       Impact factor: 6.832

Review 7.  Bone Tissue Engineering.

Authors:  Cameron R M Black; Vitali Goriainov; David Gibbs; Janos Kanczler; Rahul S Tare; Richard O C Oreffo
Journal:  Curr Mol Biol Rep       Date:  2015-08-15

8.  Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by metabolic reprogramming.

Authors:  Silvia Selleri; Panojot Bifsha; Sara Civini; Consiglia Pacelli; Mame Massar Dieng; William Lemieux; Ping Jin; Renée Bazin; Natacha Patey; Francesco M Marincola; Florina Moldovan; Charlotte Zaouter; Louis-Eric Trudeau; Basma Benabdhalla; Isabelle Louis; Christian Beauséjour; David Stroncek; Françoise Le Deist; Elie Haddad
Journal:  Oncotarget       Date:  2016-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.